May 9, 2022
Which direction will it be?
Back before BD spun off their diabetes unit, we noted this was perhaps the least sexy business in our wacky world. Sexy or not however it is also one of the most profitable units. The company literally owns the needle and syringe market effectively controlling 80%+ of the market. They have few real competitors and own a boatload of IP. Making sharp objects that stick people might be boring, but it is also one hell of a business.
Now standing alone as embecta the company has stated they want to go beyond making sharp objects that stick people and venture . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.